Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Illustration of a hip fracture

In the UK, the National Health Service (NHS) has set standards for hip fracture care which identify seven indicators that doctors and healthcare providers are recommended to provide to improve patient outcomes and quality of life.

“These performance indicators are part of the UK NHS Best Practice Tariff (BPT) where providers are reimbursed based on the care delivered in the period following injury,” said Matthew Costa, Professor of Orthopaedic Trauma Surgery at Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS).  “But it’s not clear whether the tariff is associated directly with improved patient outcomes or really how much difference each aspect of care makes to a person’s recovery. Through the WHiTE study we could test the seven recommendations to see which had the greatest impact and whether some should be prioritised by hospitals.”

Read the full story on the NDORMS website

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.